Laura Shawver, Silverback
Laura Shawver is about to join a lineup of biotech CEOs enjoying overnight fortunes, courtesy of the biotech IPO boom
Laura Shawver capped 2019 with an $88 million windfall from the sale of Synthorx to Sanofi. And she pivoted right back into the sweet …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
